Objective: Understanding the relationship between chronic pain and neurocognition has important implications for the assessment and treatment of patient experiencing pain. This paper provides an overview of the current literature examining the neurocognitionchronic pain relationship and suggests future avenues of research, along with a discussion of clinical implications of the literature findings. Consideration of potential moderators and mediators of this relationship, as well as a brief discussion of the importance of future research in special populations at particular risk for these problems, are also a focus of this paper.
C hronic pain (ie, pain persisting beyond 3 to 6 months) ranks among the most significant health issues of the 21st century. 1, 2 According to a 2011 Institute of Medicine report, 3 as many as one-third of the adult US population experiences chronic pain, resulting in an annual cost of $635 billion in medical treatment and lost productivity. In addition to adverse effects on quality of life and functioning (eg, social and occupational impairment), neurocognitive abnormalities (eg, concentration and memory problems) may also accompany chronic pain, possibly reflecting shared neural mechanisms. The purpose of this systematic review is to summarize the literature on the relationship between chronic pain and neurocognitive performance. The current review extends the findings of existing systematic reviews by expanding the focus of previous reviews to include a broader range of chronic pain conditions and neurocognitive domains rather than focusing exclusively on single conditions (eg, fibromyalgia [FM]) or specific neurocognitive domains (eg, working memory). The review additionally extends the literature by considering potential mediators and moderators of the effects of pain on neurocognition and by discussing opioids and mood symptoms as potential moderators in the association between chronic pain and neurocognition. The review also considers the implications of chronic pain and neurocognition among populations presumably at increased risk for injuries (eg, traumatic brain injury [TBI] ) that may lead to both chronic pain and neurocognitive impairment.
The following research questions guided the literature search: (1) are there domain-specific neurocognitive impairments associated with chronic pain?; (2) what factors potentially mediate or moderate the relationship between chronic pain and neurocognitive performance?; and (3) what are the implications for populations with comorbid pain and TBI, such as military populations?
METHODS
We included clinical studies of adult chronic pain samples in which neurocognition was measured via performancebased neuropsychological assessment. We excluded studies focusing on cancer-related pain, as pain secondary to malignancy may be of a vastly different etiology and is managed differently in clinical practice. Studies of nonclinical samples, experimentally induced pain, or acute pain were also omitted. Although an important consideration in understanding the relationship between neurocognitive performance and chronic pain, studies examining neural mechanisms potentially underlying both conditions were excluded as these are beyond the scope of the current study.
Literature searches were conducted in Ovid MED-LINE and the Cochrane Database of Systematic Reviews for literature published from 1980 through March 30, 2016 . Additional studies were identified from bibliographies and review papers. Included articles were all original studies (clinical trials, cross-sectional designs, pilot studies) and English language. Search terms included: pain terms (pain, chronic pain, opioids, opiates) + neurocognitive relevant terms (neurocognition, cognition, cognitive function, neuropsychological function, attention, memory, executive function, processing speed, psychomotor) + veteran and military and were entered in combination for maximum inclusivity in searches. Initially, all search terms were a combination of 1 term from the pain category and 1 term from the neurocognitive category. Second, terms with positive results were reentered, along with military or veteran. For example, search terms such as chronic pain+neuro-cognition+veteran were used. Two authors (D.M.H. and A. M.M.) reviewed the abstracts identified from the searches. Full-text articles of potentially relevant abstracts were retrieved for further review. Reference lists of relevant articles were reviewed for additional citations. The initial literature searches revealed a large number of potentially relevant citations (N = 16, 194) describing the relationship between chronic pain and neurocognition. After removing duplicates and non-English language papers, 1152 citations were retrieved and considered for inclusion. Of those, 53 citations met inclusion criteria for this review; the remaining were excluded for the following reasons: no chronic pain sample in clinical studies of neurocognitive functioning, interventional studies (eg, cognitive interventions, pharmacologic agents), or no direct assessment of neurocognitive performance. Figure 1 provides a flowchart of studies included and excluded. The studies included in this systematic review contained a total of 7430 participants (4850 with chronic pain conditions and 2580 designated as control, or comparison participants).
LITERATURE SUMMARY Neurocognitive Impairment
We included studies examining neurocognitive performance in domains judged to be particularly relevant to daily functioning (ie, processing and psychomotor speed, attention and executive function, memory and learning) and that included pain-related variables such as pain intensity and functional interference. Table 1 outlines the cognitive domains assessed, tests administered, comparison condition, and outcomes for each study.
Processing and Psychomotor Speed
Chronic pain conditions, especially those associated with functional impairment, have been associated with decrements in both processing speed (ie, the speed with which a cognitive operation is performed) and psychomotor speed (ie, the speed in which tasks with a motor component are performed). 21, 35 For example, compared with demographically similar healthy adults, adults with diabetic peripheral neuropathy demonstrated deficits on tasks of psychomotor speed, visual scanning, and rapid decision making. 20, 40, 41 Although neuropathy is not always painful, it is frequently associated with physical discomfort reflecting symptoms of burning, cold, and tingling, often likened to pain. Diabetes is frequently associated with cerebrovascular disease, which may have contributed to the findings in these studies. 20, 40, 41 To that end, the authors of the study found a link between diabetic retinopathy, commonly thought to be associated with microvascular changes, and psychomotor slowing, supporting a cerebrovascular explanation for the relationship between neuropathy and psychomotor slowing through disruption of certain neurotransmitter pathways. 41 Cardiovascular mechanisms, however, cannot account for the relationship between pain and psychomotor slowing in all pain popluations, as similar findings have emerged among patients with other pain conditions not necessarily involving a cardiovascular component, such as chronic widespread pain, 37 chronic pancreatitis, 36 and FM, who show poorer performance on tests of processing speed 19, 39, 43 and psychomotor speed, 43, 46 than healthy and/or pain-free control participants or normative data. Older patients with osteoarthritis 34 and other pain conditions 52 performed more poorly on tests of psychomotor speed (eg, grooved pegboard; finger tapping) compared with pain-free age-matched peers and compared with younger participants with similar pain conditions, although age may be an influencing factor. 52 Taken together these data suggest that most chronic pain conditions are associated with at least mild to moderate reductions in psychomotor function, particularly in older patients. More specifically, 12 of 13 studies (11 of which included a control comparison condition) examining processing speed among participants supported decreased performance among those with various pain conditions. In the one study that did not demonstrate impairment in processing speed among patients with FM compared to controls, higher pain ratings appeared to be associated with increased reaction times. 9 
Attention and Executive Functioning
Attention and executive functioning are discussed together, as the 2 constructs are somewhat fluid and partially overlapping. On tasks of attention and executive functioning, several cognitive processes have been evaluated in patients with chronic pain: selective attention, sustained attention, working memory, organization/planning, cognitive flexibility, inhibitory control, and reward sensitivity. A number of studies support significant disruptions in selective and sustained attention and working memory among chronic pain patients. 6, 7, 9, 13, 18, [20] [21] [22] 29, 56, 57 For example, patients with FM 8, 12, 13 and rheumatoid arthritis 4 appear to demonstrate selective attention deficits (ie, the ability to focus on a particular stimulus while ignoring competing stimuli). 4, 12 In addition, a review and meta-analysis of 24 observational studies noted a moderate effect size for impaired working memory, often categorized as a more complex form of attention, in patients with a variety of chronic pain conditions, compared with healthy controls. 58 The majority (20) of the 22 studies examining attention showed impairment among patients with chronic pain conditions and 15 of these studies included a control condition. The results of these studies cut across pain conditions to include those with chronic whiplash-associated disorder (WAD), chronic musculoskeletal conditions, FM, rheumatoid arthritis, diabetic neuropathic pain and discomfort, and low back pain, suggesting that chronic pain, in general, may negatively affect performance in tasks requiring an attentional component.
In several studies, patients with mixed chronic pain, 14,17 FM, 7, 10, 15, 19 chronic WAD, 5, 6, 16 and rheumatoid arthritis 4 largely demonstrated impairment in aspects of executive functioning (eg, cognitive flexibility, reward sensitivity). 4 flexibility, on the Wisconsin Card-Sorting test compared with healthy controls. 51 Executive functioning may include riskbased decision making, thought to be impaired in chronic pain. 44, 55 A preliminary study (N = 30) suggests that patients with FM showed high sensitivity to immediate gains at the expense of future losses, as compared with controls, on the Iowa Gambling task, a task of decision making in the context of varying reward and punishment contingencies. 48 Chronic pain patients demonstrated impaired probabilistic learning, perseverating responses that yield high immediate gains but higher future losses, although these patients also exhibited more random, less perseverative behavior than healthy controls. 48 Results of these studies of risk-based decision making suggest that additional research is necessary to further explore the role of chronic pain in executive functioning in FM patients and to determine whether reward-based decision making is altered in other chronic pain conditions. In contrast, other studies examining executive functioning in FM revealed mixed findings, with some demonstrating deficits compared with those without FM 46, 47, 55 and others not, 43, 54 highlighting the possible influence of mediating and moderating factors, discussed in detail below.
Screening

Included
Eligibility
Identification
Records screened (n=16,194)
Full-text articles assessed for eligibility (n=1,152)
Number of full-text articles excluded (n =1,099)
• non-chronic pain sample pain in studies of neurocognitive assessment testing
• studies of non-clinical samples or induced-acute pain with no focus on neural mechanisms
• outcomes of a cognitive-oriented intervention on pain
• studies of pharmacologic agents for pain conditions with hypothesized cognitive effects
• observational studies with no direct assessment of cognitive function in the context of chronic pain
• self-reported cognitive impairment
• pediatric sample
• cancer-related pain Attention Chronic mixed (n = 24) with test-retest following analgesic intervention NRS TEA; RST; SST Two thirds of the sample showed clinically significant disruption of attention associated with impaired working memory processes. TEA, RST, and SST scores did not differ between conditions. The maintenance of the memory trace is affected by chronic pain during task performance for those with the greatest attention impairment (P < 0.05) Dick et al 10 Attention FM (n = 30) vs. pain-free controls (n = 30) NRS; MPQ TEA; ACT; RST Patient groups performed poorer on overall attentional scores (TEA; P = 0.002) and auditory verbal working memory (TEA; P = 0.006), attentional resource capacity (RST; P = 0.01 to 0.005), and attentional functioning (ACT; P = 0.043) Eccleston 11 Attention Chronic, nonmalignant mixed (n = 26) vs. 12 pain-free controls VAS; NRS; MPQ Numerical interference task
Longer latency in reaction time for high pain group (P < 0.01) compared with low and no-pain groups. Significant interaction between task difficulty and pain on reaction time (P < 0.01) with increasing difficulty associated with poorer reaction time for the high pain group Grace et al 12 Attention Complications from diabetes associated with poorer sustained attention (DVT; P < 0.002), visual scanning and rapid decision making (EFT; P < 0.001), and hand-eye coordination (GP; P < 0.0001) compared with nondiabetic controls. Compared with other complications from diabetes, DSP was best predictor of performance for sustained attention (DVT; R 2 = 0.062, P < 0.002), visual scanning and rapid decision making (EFT; R 2 = 0.046, P < 0.007), hand-eye coordination (GP; R 2 = 0.087, P < 0.000) and mental flexibility (TMT; R 2 = 0.027, P < 0.042) Sjogren et al 21 Attention Chronic nonmalignant, mixed (n = 91) vs. healthy controls (n = 64) VAS CRT; FTT; PASAT; MMSE Sustained attention (CRT; P = 0.0368 and 0.0168) and psychomotor speed (FTT; P < 0.0001 and 0.0001) were impaired in patients compared with controls. No differences found on MMSE Migraine without aura (n = 24), within patients during and not during migraine attack VAS CVLT; Stroop test Significant differences were observed in Stroop word reading, CVLT total learning (p¼0.01), CVLT short-term recall with and without semantic help, and delayed recall with and without semantic help. Pain intensity during an attack was found to influence CVLT short-term free recall Grace et al 12 Memory FM (n = 30) vs. health controls (n = 30)
MPI-PS WMS-R; RAVLT; PASAT; SDMT Pain patients performed poorer on general memory (P < 0.02), verbal memory (P < 0.02), and delayed recall (P < 0.03) compared with controls. No significant differences were found on the RAVLT (Continued ) In bivariate analyses, pain severity was negatively related to attention and concentration (r = −0.28, P < 0.05), constructional ability (r = −0.37, P < 0.01), memory (r = −.36, P < 0.01), and reasoning ability (r = −0.29, P < 0.05). Pain did not predict attention and concentration or reasoning ability when education was controlled.
After controlling for education, pain remained a significant predictor of memory, accounting for 7% of the variance (P = 0.02) Kewman et al 29 
Memory
Chronic, musculoskeletal pain, mixed (n = 73) MPQ; VAS NCSE Pain was negatively correlated with performance on a neurocognitive screener (P = −0.475, P < 0.001) at an initial appointment and remained significant when education was controlled (r = −0.301, P < 0.001). At a follow-up visit, this correlation remained (r = −0.313, P < 0.01), but not when controlling for education Meyer et al 30 Memory FM patients performed more poorly than the agematched control group on measures of free recall (P = 0.005), recognition memory (P = 0.035), and verbal knowledge (P = 0.001). Performance on verbal fluency was marginally worse in the FM patients compared with the age-matched controls (P = 0.055). There was a significant negative correlation between AIMS pain subscale and free recall (r = −0.607, P = 0.002) and recognition memory (r = −0.555, P = 0.005). The MPQ correlated with free recall (r = −0.441, P = 0. Patients demonstrated increased muscular responding to an aversive visual stimuli during habituation (P < 0.05) and acquisition (P < 0.05) compared with controls. During extinction muscular responses to aversive (followed by shock) and pleasant visual stimuli (not followed by shock) were similarly elevated for patients only. EEG differentiates between the conditioned stimuli in controls, but not patients Controls were more accurate on a visual-spatial decision-making task (MT; P = 0.005) and had faster reactions times on a button pressing task (PVT; P = 0.001; FCRTT; P = 0.0001) compared with CBP patients. Pain was correlated with latency on a logical reasoning task (LRRT; r = 0.698, P < 0.001) and accuracy in a memory probe task (MST; r = −0.375, P = 0.003) and a visual-spatial decision-making task (MT; r = −0.301, P = 0.019) Jongsma et al 36 Processing
Chronic pancreatitis was associated with significantly poorer performance in all 3 cognitive domains compared with controls. In addition, longer pain duration was associated with poorer cognitive performance. Psychomotor performance and executive functioning showed the greatest cognitive decline, with memory performance being the least effected cognitive function in patients Lee et al 37 Processing The diabetic group performed slower on psychomotor efficiency (P < 0.0001), poorer on spatial information processing (P = 0.037) compared with controls. Neuropathy score continued to contribute to the variance of psychomotor performance after controlling for age and sex (multiple r 2 = 0.189, P = 0.012) Ryan et al 20 Processing Complications from diabetes associated with poorer sustained attention (DVT; P < 0.002), visual scanning and rapid decision making (EFT; P < 0.001), and hand-eye coordination (GP; P < 0.0001) compared with nondiabetic controls. Compared with other complications from diabetes, DSP was best predictor of performance for sustained attention (DVT; R 2 = 0.062, P < 0.002), visual scanning and rapid decision making (EFT; R 2 = 0.046, P < 0.007), hand-eye coordination (GP; R 2 = 0.087, P < 0.000) and mental flexibility (TMT; R 2 = 0.027, P < 0.042) Ryan 41 Processing Both patient groups performance poorer on an emotional decision-making task (IGT; P < 0.004), compared with the controls. In CBP patients there was a strong negative correlation between pain intensity and performance on the emotional decision-making task (IGT; r = −0.75, P < 0.003). There was not a significant relationship between pain intensity and performance on this task in the CRPS group Attal et al 45 Executive ROCFT; TMT After controlling for anxiety, depression and coping strategies, the presence of clinical meaningful pain at 6 and 12 months was predicted by poorer cognitive performance in the TMT-B (P = 0.0009 and 0.02, respectively), ROCFT copy (P = 0.015 and 0.006, respectively) and recall (P = 0.016 for pain at 12 months), for the total group of patients. Impaired scores on these tests predicted pain intensity (P < 0.01) and neuropathic symptoms in patients with pain (P < 0.05). 
FM diagnosis made via medical interview
Iowa gambling task A heuristic model of risky-decision making was also able to differentiate between healthy participants and those with fibromyalgia at the group-level and the individual-level. The mathematical model best fit those with FM when decisions were not based on previous choices and when gains were considered more relevant than losses. Conversely, among healthy controls, the best fit occurred when decisions were based on prior experience and losses were more relevant than gains In the younger age group, pain ratings were inversely related to memory and executive function. In the older age group, a positive relationship was found between pain ratings and executive function, whereas the inverse association of pain with memory was no longer present. On the Stroop test reading performance was slower in patients on opioid medication compared with the nonopioid (P = 0.02) Scherder et al 53 Executive functioning 
Learning and Memory
Studies of individuals with FM, WAD, osteoarthritis, migraine headache, and low back pain have demonstrated deficits in a number of aspects of learning and memory (eg, short-term memory, learning, retention, implicit memory, conditioned learning/extinction) among patients with these conditions. 6, 12, [25] [26] [27] 33, 34, 53, 56, 59 For example, in a sample of FM patients who were compared with older adults and controls, Park demonstrated that patients with FM performed less proficiently on tasks of free recall when the recall occurred immediately following presentation of stimuli (ie, short-term memory) than age and educationmatched controls, but performed similarly to educationmatched controls who were 20 years older. 59 Although FM patients perform more poorly on tests of immediate and delayed recall, these patients' self-reported symptoms of memory difficulties may far outweigh the observed deficits. 12 Verbal learning and memory impairments (ie, immediate recall, learning speed, forgetting rate) have also been demonstrated in a sample of patients with chronic WAD compared with patients with neurological disease (ie, neurologist-diagnosed central nervous system disease or brain injury visible in computed tomographic scan or magnetic resonance imaging) and patients with anxiety or depression. 6 Nearly all studies (15/16) examining tests of learning and memory reported relatively impaired performance in various aspects of memory among patients across all studied chronic pain conditions. However, given the large range of tests of memory used in these studies, it is difficult to draw concluding inferences about which aspects of memory (eg, initial registration vs. retrieval) are consistently affected in patients with chronic pain conditions. In addition, only half of these studies included a control condition, calling the methodological rigor of the studies into effect. Interestingly, several of the studies examining learning and memory also examined moderators of the neurocognition and chronic pain relationship, such as opioid use, mood symptoms, and pain intensity, described below.
MEDIATORS AND MODERATORS OF THE RELATIONSHIP BETWEEN CHRONIC PAIN AND NEUROCOGNITIVE FUNCTION
A number of factors have been hypothesized to influence and/or account for the association between performance on tasks measuring neurocognition and chronic pain, including cognitive load, age, FM, patient sex, pain severity, mood symptoms, and opioid use. For tests of attention and executive functioning, some evidence suggests cognitive load and pain severity may interact 11 ; specifically, on complex attention tasks with high cognitive demand, patients with high (vs. low) pain intensity demonstrated greater impairment. In contrast, other studies have not supported a cognitive load hypothesis, but rather favor psychomotor slowing as a moderator between pain and alteration in working memory performance. 18 Age may be a mediator of performance on tests examining components of attention or executive functioning (eg, Stroop test, trail making test-Part B [TMT-B]) in patients with chronic pain compared with the general population, 4, 14, 38, 45, 52 as well as on tests of psychomotor speed (eg, grooved pegboard; finger tapping). 52 Factors that may account for the mixed results of some studies of fibromyalgia and executive functioning include variation among tests of executive functioning, participants' sex (predominantly female), the nature of FM, which typically includes symptoms of fatigue and depression, and as a methodological concern, statistical power of the studies. Pain severity reported at the time of neurocognitive testing appears to have moderated the results in the relationship between pain and neurocognitive functioning in a number of studies. More specifically, higher pain intensity among groups with chronic pain conditions is associated with less proficient processing speed performance. 9 This same relationship between pain intensity and attention and executive functioning is not found among patients with chronic postconcussive pain and mild TBI who reported pain in the 2 weeks before testing. 23 Chronic pain patients with higher emotional distress have demonstrated impairment in immediate and delayed recall of verbal and nonverbal memory tasks compared with those with lower emotional distress, suggesting that mood symptoms may also moderate the relationship between pain and memory processes. 27 
The Role of Opioid Analgesics in Neurocognitive Function
Opioid analgesics constitute another major mediator of the relationship between pain and neurocognitive function because of their effects on the central nervous system and frequent use as a treatment for pain. Although a complete review of the literature describing the role of opioid analgesics in neurocognitive dysfunction is beyond the scope of the current review, their frequent use for chronic pain warrants a summary of the recent findings from the literature, focusing on those studies that examined neurocognitive functioning in patients with chronic noncancer pain who received opioid analgesia. Ersek et al 60 reviewed 6 studies published between 1990 and 2003 of patients with chronic nonmalignant pain treated with opioids and noted conflicting results. Whereas some of the studies reviewed by Ersek and colleagues reported impairments in working memory, attention, and processing speed associated with opioid use, as compared with chronic pain patients not receiving opioids or healthy control participants, others found no neurocognitive deficits in patients treated with opioids.
Similar to previous studies reviewed by Ersek and colleagues, the findings of more recent studies examining the relationship of opioid use to neurocognitive functioning suggest neurocognitive impairment in some domains, but not others, among patients taking opioid analgesics. 60 For example, chronic pain patients receiving long-term opioid medications ( > 3 mo) performed less proficiently on a task requiring alternation of numerical and alphabetic sequences (TMT-B) compared with normative data, despite normal function in other domains of neurocognitive function (ie, psychomotor speed and attention/working memory). 50 Another study comparing low back pain patients with healthy controls found that chronic opioids can further impair performance on tasks requiring complex attention (TMT-B ratio). 42 This latter study , which included a comparison sample of chronic pain patients who were not receiving opioid analgesics, demonstrated that the opioidtreated chronic pain patients performed more poorly, 42 suggesting that there is some evidence for the role of opioids in complex attention. In a study comparing patients with chronic pain treated with opioid analgesics at a multidisciplinary pain clinic, Sjogren and colleagues found that opioid treatment was associated with impairment in information processing and working memory in patients with chronic pain compared with controls who did not have chronic pain and were not receiving opioids and compared with nonmedicated patients with chronic pain. 21 Patients receiving long-term opioids alone (median morphine equivalent daily dosage [MEDD] 60 mg); however, did not perform differently than either those receiving antidepressant/anticonvulsants or those receiving the combination of the 2 (those receiving antidepressant/anticonvulsants and long-term opioids had a median MEDD of 90 mg). Overall, there were no associations between MEDD, pain duration, or type of analgesic with neurocognitive performance. However, there were associations between sedation (presumed to be a side effect of opioids, which may indicate an effect of opioids) and reaction time, and between pain intensity and information processing/working memory. 21 The study found no relationships between specific opioid analgesics or combinations of opioid analgesics and nonopioid analgesics and neurocognitive performance. 1 In many of the studies examining the role of opioids in neurocognition among patients with chronic pain, it is difficult to determine with certainty that the deficits are the result of opioid analgesics, as opposed to pain or other variables. Several methodological limitations of these studies included small sample size, nonrandomized samples, limited neurocognitive testing, and inadequate experimental design and controls. Other studies have demonstrated either no significant effect or an enhancing effect of opioids on neurocognitive functioning. [61] [62] [63] For example, Kurita and colleagues used a cross-sectional design of 49 patients with chronic noncancer pain who had been treated with opioids for a minimum of 3 months. Similar to other studies, [61] [62] [63] results of this study did not support evidence of neurocognitive impairment in patients treated with opioid analgesics in the domains of attention, working memory, psychomotor speed, and general cognitive functioning, but did demonstrate a deficit on the TMT-B, which primarily assesses motor function, attention, and mental flexibility. 50 In addition, exploratory analyses of this study revealed that female sex, increased age, lower education, lower income, lower opioid doses, fatigue, sleep duration, anxiety, and depression were associated with relative neurocognitive impairment. 50 Some of these associated factors (eg, sleep, anxiety, and depression symptoms) are clinically addressable and may inform treatment approaches for patients with chronic pain on opioid therapy. Poor neurocognitive performance was associated with lower opioid doses, suggesting that, if a pain generator is adequately treated (ie, in this case, through use of opioid analgesics in this particular sample of patients), neurocognition may improve. This is in contrast to the hypothesis that increased opioid dose produces greater neurocognitive impairment, presumably as a result of opioid side effects.
Tolerance to opioids, opioid-mediated pain treatment, and negative mood associated with opioid treatment may each be factors that contribute to variability in neurocognitive impairment in opioid-treated chronic pain. Delineating the role of pain and role of opioids in the neurocognitive deficits found in other studies is difficult, as many of the studies did not include multiple comparison arms such as chronic pain not treated with analgesics, chronic pain treated with nonopioid analgesics, and chronic pain treated with opioid analgesics, nor were all of these studies longitudinal in design. Despite the challenges, it appears that recent research suggests opioid analgesia may improve some aspects of neurocognition in patients, likely via reduced pain and related affective distress. Overall these studies support the notion that neurocognitive disruption associated with chronic pain cannot be considered simply an epiphenomenon due to pain medication.
Summary of Neurocognitive Performance in Individuals With Chronic Pain
Overall, review of clinical studies of neurocognitive performance in chronic pain samples strongly supports a relationship between chronic pain and neurocognitive performance decrements, particularly on tests of memory, processing speed, and attention, and particularly among older patients and those with FM. The majority of the demonstrated impairments occurred without regard to the specific pain condition (although FM was disproportionately represented in these studies). Most studies also included control comparison conditions, indicating some methodological rigor, with the exception of the studies examining learning and memory. Despite this growing evidence base, some studies reviewed above (n = 5) did not find an association between chronic pain and certain neurocognitive processes (eg, memory; aspects of attention; cognitive inhibition). 23, 43, 50, 53, 54 Some of the studies presented indicated a potential role for emotional distress in the neurocognitive performance of patients with chronic pain conditions as well as a potential moderating roles for age, pain severity, cognitive load, and opioid use. Further investigation of these moderators may yield additional information to better understand neurocognitive function in patients with chronic pain.
CLINICAL CONSIDERATIONS: NEUROCOGNITIVE ALTERATION AND ENGAGEMENT IN PAIN TREATMENT
Understanding the relationship between chronic pain and neurocognition has important implications for the treatment of pain (eg, adhering to pain medication or physical therapy regimen; participating in behavioral pain self-management programs), and the development of new treatments. Untreated pain may be associated with neurocognitive impairment in domains such as memory, attention, processing speed, and executive functioning and may also contribute to emotional distress, all of which could affect patients' abilities to engage in pain self-management and contribute to loss of global functioning. However, from the review of the literature, it is difficult to determine the direction of the relationship between pain and neurocognitive impairment (eg, does pain lead to neurocognitive impairment or do those with neurocognitive impairment represent higher risk for chronic pain that is associated with functional impairment?). For example, if cognitive impairment reduces pain tolerance in some manner, then patients at risk for cognitive impairment (eg, those with TBI, those with Alzheimer disorder and other disorders of aging) would be at particular risk for chronic pain and may need more intensive screening or treatment.
On the basis of the data suggesting that there is a relationship between chronic pain and neurocognitive performance, researchers have discussed the effects these deficits may have on assessing and treating chronic pain. For example, with respect to behavioral therapies for pain, chronic pain patients with neurocognitive impairments may benefit from modification in presentation of skills (eg, using more handouts and in-session demonstration, supplementing with technological aids such as smartphone applications). Addressing mental health conditions, such as depression, which can also contribute to neurocognitive changes in attention and concentration, may improve patient outcomes in terms of both pain and neurocognitive function. More research is essential before making specific recommendations regarding modification of pain management practices to accommodate patients with chronic pain and cognitive impairment.
SUMMARY AND CONSIDERATION FOR POPULATIONS AT RISK FOR PAIN AND NEUROCOGNITIVE IMPAIRMENT
Impairments have been demonstrated in several neurocognitive domains including attention, memory, processing speed, and executive function. More recently, researchers have begun to explore underlying neural mechanisms common to both pain and neurocognition to better understand the nature and direction of this relationship. A thorough examination of the literature investigating neural mechanisms common to both pain and neurocognitive functioning was not reviewed in the current study; however, these relationships warrant further examination. Importantly, there are a number of factors that may mediate the relationship between chronic pain and neurocognitive functioning, such as medication side effects, although evidence for the role of opioids in neurocognitive impairment among these patients is also mixed (eg, some suggesting improvement in cognitive functioning with hypothesized improved control and other results suggesting that memory and attention are impairment are likely opioid side effects) with inconsistent use of sound methodology in experimental design.
In addition to increasing research on neural mechanisms common to both pain and neurocognition and mediators and moderators of the relationship between pain and neurocognition, it is important to examine populations at heightened risk for chronic pain and neurocognitive impairment, including populations who sustain TBI and/or concurrent orthopedic injuries such as motor vehicle accident victims, professional sports players, military service members, and others whose lifestyles may be especially conducive to injuries related to these problems. Older adults at risk for both cognitive disorders of aging and injuries and illness associated with pain may likewise both show pronounced cognitive impairment and experience chronic pain.
As a specific example, the recent wars in Iraq and Afghanistan have highlighted the significance of chronic pain and associated neurocognitive deficits because of the relatively high frequency of each among warzone veterans, 64, 65 and the complex clinical context in which chronic pain and neurocognitive deficits occur in warzone veterans. For Iraq and Afghanistan War veterans, chronic pain constitutes a component of the "polytrauma triad," along with TBI and posttraumatic stress disorder (PTSD). A recent review of medical record data indicated that 93% of a polytrauma clinic sample reported TBI, with 81% of the sample reporting pain. 66 Thus, among the spectrum of adverse psychosocial outcomes accompanying pain, cognitive impairment may be particularly relevant to returning veterans with both pain conditions and TBI. 67, 68 Even among chronic pain patients without TBI, as many as 54% report neurocognitive deficits (eg, attention, forgetfulness). 69 A notable limitation of the literature is that few studies focus on performance task measurement of neurocognitive function or neuroimaging in military service personnel and veterans with chronic pain and related comorbid conditions (eg, TBI). This is surprising, given the high rates of chronic musculoskeletal pain and TBI relative to nonveteran samples. A 2009 systematic review of 95 studies (93 were cohort studies) examining pain in patients with TBI indicated that many of the included studies did not assess (or contained limited data) regarding pain indicators such as intensity, and functional interference among patients with TBI-related neurocognitive impairment. 70 These studies did suggest some early evidence for the roles of depression, PTSD, insomnia, and fatigue in pain-related functional interference among patients with TBI. Similarly, a more recent review of the "polytrauma triad" among veterans of the conflicts in Iraq and Afghanistan suggested that cognitive deficits due to mild TBI may affect patients' ability to engage in treatment for pain and/or PTSD and encourages clinicians to focus on reducing barriers to engaging in treatment. 71 Given the complexity of these comorbid conditions and the symptom overlap between them, applying knowledge gleaned from existing literature to veterans has important implications for pain treatment outcomes and quality of life in these patients. A number of special populations present a heightened risk of chronic pain and neurocognitive impairment, including military service members and veterans, older patients, and others who sustain TBI and/or concurrent orthopedic injuries such as motor vehicle accident victims, and professional sports players. These populations of interest warrant additional research, including longitudinal studies to further examine whether the effects of neurocognitive impairment, if demonstrated, share a relationship with aging, TBI, and/ or chronic pain (although this may be difficult to determine).
Limitations
Despite gaining momentum in recent years, much of the literature examining chronic pain and neurocognitive performance must be interpreted with some caution, as certain aspects may not generalize well to clinical chronic pain patients. For example, many of the studies did not include a pain-free comparison condition. Some studies included small sample sizes. Further, many studies beyond the scope of this review examined the effect of experimentally induced, acute pain and neurocognitive performance. Such studies may fall under scrutiny because of generalizability of results. Specifically, acutely induced pain does not take into account the myriad of chronic pain concomitants nor the cumulative effect of chronic pain that likely mediate the relationship between pain and neurocognitive performance. 72 Further, although the literature search and review was comprehensive for the current study, there is a risk of bias such that there may have been an incomplete retrieval of identified research (eg, some papers deemed excluded that should have been included) or unintentional bias in reporting results of reviewed studies (eg, reporting partial findings).
conducting longitudinal neurocognitive assessment in patients with known conditions associated with chronic pain may yield insightful data, especially in terms of neurocognitive changes in response to adequate pain management. Perhaps these patients develop neurocognitive deficits at a differential temporal rate or in different areas than those without chronic pain. Further, among patients with chronic pain, controlling for confounding variables such as opioid analgesic use (eg, comparing patients with chronic pain taking opioids with those who are opioid naïve) in studies examining neurocognitive function is important to determine whether changes or differences in neurocognitive function are not mediated by the introduction of opioid medications in these patients. Given the role of tolerance to these medications, longitudinal designs may be beneficial to understanding the relation between adequate pain treatment, opioid effects and dosage, and neurocognitive performance. Finally, beyond focusing on the roles of opioids, it is evident from the literature that examination of the role of pain in neurocognition among veterans with chronic pain, both with and without TBI and other comorbidities, is lacking.
